Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

FDA approves extended shelf-life for Taxus Stent System

May 25, 2005

Novel therapeutics for cardiovascular diseases reported in recent patents

May 24, 2005

Myogen evaluates ambrisentan in PAH patients refractory to other ERA therapies

May 24, 2005

AS-6 activates sGC and induces hypotensive effects in rats

May 24, 2005

FDA approves extended indication of Atacand for treatment of heart failure

May 23, 2005

ZOMAXX II study opens enrollment

May 20, 2005

Corautus and BI enter manufacturing agreement for VEGF2 plasmid DNA

May 19, 2005

New stem cell trial to begin in heart failure patients

May 18, 2005

PulmoLAR designated orphan drug for PAH

May 17, 2005

New targets and treatments for cardiovascular disorders reported

May 11, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...